|
|
|
|
| Join Cell & Gene Live Chief Editor Erin Harris on February 19, at 11am Eastern for Building Smarter Cell Therapies with AI and Synthetic Biology. In this live event, experts will explore how AI and synthetic biology are being applied to engineer more precise, controllable, and scalable cell therapies. Register for free thanks to support from our sponsor BD Biosciences. |
|
|
FOCUS ON TRANSLATIONAL RESEARCH |
|
|
|
By Cell & Gene: The Podcast | In episode 121 of Cell & Gene: The Podcast, Host Erin Harris talks to Scribe Therapeutics' CEO and Co-Founder Benjamin Oakes about building next‑generation CRISPR and epigenetic editing tools to expand beyond rare disease into common cardiometabolic indications. | |
|
|
|
| Bridging Discovery And CMC With Rapid Pools | Webinar | Asimov | Learn how early stable CHO expression data reveals manufacturability issues in complex antibodies that transient screening misses, with case studies showing how this changes lead selection. |
|
|
|
|
|
|
TRANSLATIONAL RESEARCH SOLUTIONS |
|
|
|
|
| Connect With Cell & Gene: |
|
|
|